Strategies to Reduce HCV Incidence in Key Populations: The Role of HCV Treatment as Prevention

Tailored for clinicians practicing in the European Union this program equips participants with key strategies for effectively curing HCV in critical transmitting populations such as PWID and incarcerated individuals.

Share

Program Content

Activities

Implementing HCV TasP in Europe
Expert Perspective on Implementing HCV Treatment as Prevention in At-Risk European Populations
Congratulations: You achieved a completion on 04/09/2022
Downloadable Slideset
Strategies to Reduce HCV Incidence in At-Risk European Populations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2019

Expires: March 25, 2020

Activities

HCV TasP in France
Lessons From France on Implementing HCV Treatment as Prevention: Whom Should We Treat and How?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 23, 2019

Expires: April 21, 2020

HCV TasP in Germany
Applying HCV Treatment as Prevention in Germany: Successes and Ongoing Challenges
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 17, 2019

Expires: May 15, 2020

HCV Elimination in Spain
HCV Elimination in Spain: Overcoming Challenges in High-Risk Populations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 05, 2019

Expires: July 03, 2020

HCV TasP in Italy
HCV Treatment as Prevention in Italy: Overcoming Regulatory Barriers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2019

Expires: July 31, 2020

HCV TasP in Scotland
Collecting Real-World Data on HCV Treatment as Prevention in PWID: The Scottish Experience
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 04, 2019

Expires: September 02, 2020

No activities added yet

Faculty

cover img faculity

Alessio Aghemo, MD, PhD

Associate Professor of Gastroenterology
Department of Biomedical Sciences
Humanitas University
Division of Internal Medicine and Hepatology
Department of Gastroenterology
Humanitas Research Hospital
Milan, Italy

cover img faculity

Christopher Byrne, BA (Hons), MSc

School of Medicine
University of Dundee
Dundee, Scotland

cover img faculity

John F. Dillon, MB BS, MRCP, MD, FRCP (Edin), FRCP (Lond)

Professor of Hepatology and Gastroenterology
Division of Molecular and Cellular Medcine
School of Medicine, University of Dundee
Honorary Consultant Physician, Gastroenterologist & Hepatologist
Clinical Lead for Blood Borne Viruses

NHS Tayside
NHS Research Scotland National Lead for Hepatology
President of Scottish Society of Gastroenterology
Dundee, United Kingdom

cover img faculity

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

cover img faculity

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

cover img faculity

Marta Torrens, MD

Associate Professor
Psychiatry and Forensic Medicine
Universitat Autonoma de Barcelona
Head of Addiction Program
Institute of Neuropsychiatry and Addiction
Barcelona, Spain

cover img faculity

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Partners

INHSU

ProCE Banner